Late breaking abstracts for SCALE 2027 are now being accepted. Submit by April 9, 2027 at 12:00 am EDT
SCALE invites clinicians and researchers to present late breaking work during the main program at the 22nd edition of Music City SCALE, May 19–23, 2027, in Nashville. Selected abstracts are presented as 5-minute podium talks. Other high-quality submissions may be invited to the E-Poster Digital Discovery Lounge. The SCALE Abstract Review Committee reviews every submission for quality, originality and clinical relevance.
Key Dates
| Milestone | Date |
|---|---|
| Abstract submission deadline | April 9, 2027 |
| Acceptance notification (by email) | April 16, 2027 |
| Presenter registration deadline | April 23, 2027 |
Who Should Apply
Licensed healthcare professionals, researchers and educators presenting on aesthetic medicine, dermatology or related fields. Residents and fellows should also see the Rising Stars Program.
Presentation Opportunities
- Podium: Selected abstracts are presented in a 5-minute talk during the main program.
- E-Poster: Authors can ask to have their abstract considered for the Digital Discovery Lounge, whether or not it is chosen for the podium.
Topic Areas
Choose the topic that best fits your abstract, or suggest your own on the form.
Aesthetic Topics
- Injectables: Neuromodulators, Soft Tissue Fillers, and Biostimulators
- Lasers, Light, and Energy-Based Devices (including body contouring)
- Nonsurgical Aesthetic Procedures (threads, scar treatment, etc.)
- Surgical Rejuvenation and Cosmetic Surgery
- Combination Therapy
- Skincare and Cosmeceuticals
- Hair Restoration and Hair Loss
- Regenerative Medicine (exosomes, PRP, polynucleotides, skin boosters)
- Skin of Color Aesthetics
- Complications and Adverse Events
Longevity and Healthy Aging
- Skin Aging Science and Evidence-Based Longevity (aging mechanisms, validated biomarkers, clinical outcomes data)
- Hormonal and Metabolic Effects on Skin (menopause, GLP-1 therapy, endocrine factors)
- Implementing Longevity Services in Clinical Practice (patient selection, protocols, outcomes tracking)
Medical Dermatology Topics
- Chronic and Inflammatory Skin Conditions (acne, atopic dermatitis, psoriasis, rosacea, hidradenitis suppurativa, hyperhidrosis)
- Pigmentary Disorders and Melasma
- Skin Cancer and Actinic Keratosis
- Pediatric Dermatology
- Skin of Color Dermatology
Practice Management Topics
- Marketing, Social Media, and CRM Tools
- Private Equity, Business Models, and Practice Ownership
- Personnel Management and Supervising APPs (NPs/PAs)
- Patient Experience, Retention, and Cash-Pay Practice Growth
- Technology and AI Innovations
Abstract Guidelines
- Submit electronically through the SCALE portal. Each abstract is submitted individually. Prior submissions do not carry over, and email submissions are not accepted.
- Limit: 400 words, excluding title, authors, affiliations and supplementary materials.
- Use these sections: Title, Background, Purpose, Methods, Results and Conclusion.
- Submissions should be in English with grammar and spelling suitable for publication.
- Use generic drug and device names only. No logos or branded slide content.
- Do not include figures, tables or references in the upload.
- Conclusions must be supported by the results in your abstract.
Previous Presentation
Encore research is welcome. Mark it as an encore on the form and give the original presentation date and venue.
Publication Opportunity
SCALE is working with a journal partner The Dermatologist to publish selected 2027 E-Posters online. The submission form asks whether you would like your E-Poster considered.
Disclosure Requirements
SCALE is an accredited CME meeting, and every submission must meet CME standards.
- All authors must disclose relevant financial relationships and funding support.
- Complete Disclosure documentation in the portal. Submissions without it are incomplete and cannot be reviewed.
- Presenters may not be employees of ineligible companies as defined by the ACCME: companies whose primary business is producing, marketing, selling, reselling or distributing healthcare products used on or by patients.
- Accepted presentations undergo content review by the accredited CME provider before the meeting.
Commitment
Accepted abstracts are invited to present as part of the SCALE 2027 program. Presenters must register for the meeting as attendees (not as exhibitors or guests) and are responsible for their own registration, travel and lodging. Submission does not guarantee acceptance, and decisions of the Abstract Review Committee are final. SCALE may withdraw any presentation that does not meet CME or program criteria.